When Deep Venous Thrombosis Fails to Respond to Therapy

References

1. ↵
   Mackenzie AR, Laing RB, Douglas JG, Greaves M, Smith CC. High prevalence of iliofemoral venous thrombosis with severe groin infection among injecting drug users in North East Scotland: successful use of low molecular weight heparin with antibiotics. Postgrad Med J 2000; 76: 561–5.

   OpenUrlAbstract/FREE Full Text
2. ↵
   Mozsik G, Figler M, Gasztonyi B, et al.[Prevalence of Leiden mutation in various gastrointestinal disorders]. Orv Hetil 2002; 143: 447–50.

   OpenUrlPubMed
3. ↵
   Violi F, Ferro D, Basili S, et al. Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationship to venous thrombosis. J Investig Med 1995; 43: 550–4.

   OpenUrlPubMed
4. ↵
   Luk C, Wells PS, Anderson D, Kovacs MJ. Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy. Am J Med 2001; 111: 270–3.

   OpenUrlCrossRefPubMed
5. ↵
   Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998; 338: 409–15.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   Seligsohrn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222–31.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998; 338: 1169–73.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   Nordstrom M, Lindblad B, Anderson H, Bergqvist D, Kjellstrom T. Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ 1994; 308: 891–4.

   OpenUrlAbstract/FREE Full Text
9. ↵
   Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998; 338: 1169–73.
10. ↵
    Nakata S, Tamura S, Morishita S, Onishi S. Depressed type primary signet ring cell carcinoma of the colon: a case report. Gastrointest Endosc 2001; 54: 108–10.

    OpenUrlPubMed
11. Sarma ND, Gahukamble LN, Visweswara RH, Ramesh K, al Fituri O, Saeed SO. Primary signet ring carcinoma of the colon and rectum. Histopathology 1995; 26: 378–9.

    OpenUrlPubMed
12. Almagro UA. Primary signet-ring carcinoma of the colon. Cancer 1983; 52: 1453–7.

    OpenUrlPubMed
13. ↵
    Rau B, Below C, Haensch W, Liebrich W, von Schilling C, Schlag PM. [Significance of serum beta-hCG as a tumor marker for stomach carcinoma.] Langenbecks Arch Chir 1995; 380: 359–64.

    OpenUrlPubMed
14. ↵
    Yonemura Y, Oyama S, Sugiyama K, et al. Human chorionic gonadotropin in gastric carcinoma. A useful marker for bone metastasis. Int Surg 1989; 74: 84–7.

    OpenUrlPubMedWeb of Science
15. ↵
    Pestalozzi BC, von Hochstetter AR.[Muscle metastasis as initial manifestation of adenocarcinoma of the stomach], Schweiz Med Wochenschr 1998; 128: 1414–7.

    OpenUrlPubMed
16. ↵
    Ozdal OL, Yakupoglu YK, Cicek A, Erdem O, Memis L, Memis A. Epididymal metastasis from gastric signet ring cell adenocarcinoma. Can J Urol 2002; 9: 1498–9.

    OpenUrlPubMed